LWAY Lifeway Foods, Inc.
Dairy Products · Nasdaq · SEC CIK 814586 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY24.0%
TTM net income YoY-31.9%
TTM EPS YoY-35.1%
Revenue 3-yr CAGR18.0%
Net income 3-yr CAGR-2.1%
Margins
Gross margin22.9%
Operating margin4.7%
Net margin3.0%
FCF margin-13.9%
EBITDA margin6.4%
Returns
ROE9.0%
ROA6.3%
ROIC (approx.)11.6%
Asset turnover2.09x
Leverage & solvency
Liabilities / assets35.6%
Debt / equity0.00x
Current ratio2.32x
Interest coverage18.28x
Cash quality & payout
Operating cash flow / net income0.68x
Accruals ratio2.0%
Payout ratio—
Capex / revenue16.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $212.50M | $186.82M |
| Cost of revenue | $154.29M | $138.25M |
| Gross profit | $58.21M | $48.57M |
| SG&A expense | $21.60M | $19.44M |
| Operating income | $16.17M | $13.85M |
| Interest expense | $77,000 | $105,000 |
| Pretax income | $19.69M | $13.97M |
| Income tax | $5.83M | $4.94M |
| Net income | $13.86M | $9.03M |
| EBITDA | $20.15M | $17.24M |
| EPS (basic) | 0.91 | 0.61 |
| EPS (diluted) | 0.89 | 0.60 |
| Weighted avg. shares (diluted) | 15.54M | 15.13M |
| Balance sheet | ||
| Cash & equivalents | $5.57M | $16.73M |
| Receivables | $16.64M | $15.42M |
| Inventory | $11.89M | $8.68M |
| Current assets | $37.06M | $43.60M |
| PP&E, net | $48.28M | $26.86M |
| Goodwill | $11.70M | $11.70M |
| Intangibles | $5.82M | $6.36M |
| Total assets | $105.61M | $90.55M |
| Current liabilities | $16.64M | $15.50M |
| Total liabilities | $19.79M | $18.64M |
| Shareholders' equity | $85.82M | $71.91M |
| Shares outstanding | 15.23M | 15.10M |
| Cash flow statement | ||
| Operating cash flow | $10.95M | $12.96M |
| Capital expenditure | $27.36M | $6.70M |
| Free cash flow | -$16.41M | $6.26M |
| Investing cash flow | -$22.04M | -$6.68M |
| Financing cash flow | -$65,000 | -$2.75M |
| Depreciation & amortization | $3.98M | $3.39M |
| Stock-based compensation | $1.95M | $2.45M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.